Last €47.98 EUR
Change Today 0.00 / 0.00%
Volume 0.0
LLY On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
Sao Paulo
EN Paris
Frankfurt
As of 10:01 AM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Enrique A. Conterno

Senior Vice President and President of Lilly Diabetes, Eli Lilly and Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

47$3,009,041
As of Fiscal Year 2013

Background*

Mr. Enrique A. Conterno has been President of Diabetes Business Unit at Eli Lilly & Company since November 1, 2009 and serves as its Senior Vice President. Mr. Conterno served as the Head of the diabetes business unit at Eli Lilly & Co. since November 1, 2009. He served as Leader of Diabetes Business Unit at Eli Lilly & Co. since November 1, 2009. Mr. Conterno served as President of Lilly USA, LLC at Eli Lilly & Co. from January 2009 to November 1, 2009. He served as ...

Read Full Background

Corporate Headquarters*

Lilly Corporate Center
Indianapolis, Indiana 46285

United States

Phone: 317-276-2000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA 1992
Duke University
Bachelor's Degree 1989
Case Western Reserve University

Other Affiliations*

Annual Compensation*

Salary$680,658
Total Annual Compensation$680,658

Stock Options*

Restricted Stock Awards$1,500,000
All Other Compensation$40,840
Exercisable Options24,729
Total Number of Options24,729

Total Compensation*

Total Annual Cash Compensation$1,420,874
Total Short Term Compensation$680,658
Other Long Term Compensation$1,540,840
Total Calculated Compensation$3,009,041
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:FP €47.98 EUR 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.